INT244657

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.40
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 6.63
Pain Relevance 0.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Lch (Mus musculus)
Pain Link Frequency Relevance Heat
imagery 62 78.20 Quite High
Pain 2 29.40 Quite Low
fifth nerve 6 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
Central nervous system 2 5.00 Very Low Very Low Very Low
Morphine 2 5.00 Very Low Very Low Very Low
cva 2 5.00 Very Low Very Low Very Low
fibrosis 1 5.00 Very Low Very Low Very Low
Neuritis 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Langerhans-cell Histiocytosis 61 100.00 Very High Very High Very High
Nasopharynx Cancer 7 100.00 Very High Very High Very High
Hodgkin's Disease 3 100.00 Very High Very High Very High
Metastasis 31 99.80 Very High Very High Very High
Genetic Predisposition To Disease 2 99.80 Very High Very High Very High
Myelodysplastic Syndromes 38 99.00 Very High Very High Very High
Leukemia 57 98.76 Very High Very High Very High
Bone Cancer 21 97.92 Very High Very High Very High
Neuroblastoma 1 96.56 Very High Very High Very High
Cancer 114 95.96 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Therapy administered to control LCH and genetic predisposition may be possible explanations [12].
Regulation (control) of LCH associated with langerhans-cell histiocytosis and genetic predisposition to disease
1) Confidence 0.40 Published 2008 Journal Cases J Section Body Doc Link PMC2527498 Disease Relevance 2.19 Pain Relevance 0
However, immunosupressive and cytotoxic chemotherapy as well as radiotherapy given to control LCH may be complicated by t-MDS/t-AL.
Regulation (control) of LCH associated with leukemia, langerhans-cell histiocytosis and myelodysplastic syndromes
2) Confidence 0.18 Published 2008 Journal Cases J Section Body Doc Link PMC2527498 Disease Relevance 2.14 Pain Relevance 0
A biopsy is required for final diagnosis, treatment being different for NPC, non-Hodgkin lymphoma (NHL), LCH and metastatic disease.


Regulation (different) of LCH associated with langerhans-cell histiocytosis, nasopharynx cancer, hodgkin's disease and metastasis
3) Confidence 0.03 Published 2010 Journal Pediatr Radiol Section Body Doc Link PMC2950273 Disease Relevance 2.30 Pain Relevance 0.13

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox